SUBSCRIBE
SUBSCRIBE
News   Drug Development

Sorafenib Shows Promise For Heart-Lung Disease; Cancer Drug Interferes With Abnormal Cell Growth Seen In Pulmonary Hypertension, University of Chicago Study

May 21, 2008 | 
1 min read

HealthDay News -- The cancer drug sorafenib (Nexavar) shows promise as a treatment for pulmonary hypertension, according to a University of Chicago Medical Center study.

Clinical research Postmarket research
MORE ON THIS TOPIC
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
March 13, 2025
 · 
1 min read
 · 
Lori Ellis
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Autoimmune disease
Amgen’s Uplizna Deepens Response Against Myasthenia Gravis at 1 Year
March 13, 2025
 · 
1 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Entrance to Pfizer's office in Belgium
Breast cancer
Pfizer, Arvinas Post Mixed Late-Stage Breast Cancer Data for Closely Watched PROTAC Drug
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac